Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.
Explore the PTAB proceeding IPR2023-01044 filed by Novartis Gene Therapies, Inc. et al. on 2023-06-30. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2023-01044
Filing Date
2023-06-30
Accorded Filing Date
2023-06-30
Institution Decision Date
2024-01-09
Last Modified Date
2024-03-04
Proceeding Type
IPR
Termination Date
2024-03-04
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Novartis Gene Therapies, Inc. et al.
Represented By
Livingstone, Johnet alPatent Owner / Respondent
Genzyme Corporation et al.
Represented By
Antons, Amandaet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 36844 | Joseph Kirk Jr | +1 908-981-6911 |
| 39150 | John Conway | +1 908-981-6688 |
| 40564 | Anne Collins | +1 978-341-0036 |
| 44045 | Sandra Brockman-Lee | +1 857-523-9199 |
| 45736 | Pamela Torpey | +1 508--27-1-0683 |
| 45979 | Milan Vinnola | +1 619-238-0062 |
| 47150 | Nicole Parsons | +1 617-685-5697 |
| 52610 | Kelly Bender | +1 248-593-0581 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 10,429,288 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2015621057 | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2016118520 A1 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 11,639,887 B2 | US Continuation / Sibling | View Official Patent → |
Novartis Gene Therapies, Inc. et al. v. Aventis, Inc. et al.
Genzyme Corporation v. Novartis Gene Therapies, Inc.